Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia. II. Dose- response effect and the therapeutic window

Journal of Neurosurgery

Volumn 85, Issue 6, 1996, Pages 1108-1112

  Yanaka, Kiyoyuki ^a   Spellman, Stephen R ^a   Mccarthy, James B ^a   Low, Walter C ^a   Camarata, Paul J ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Neurology/Neurosurgery   (United States)

Author keywords

adhesion molecule; cerebral ischemia; heparin; leukocyte; rat

Indexed keywords

HEPARIN; MYELOPEROXIDASE;

ANIMAL MODEL; ANTICOAGULANT THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL ADHESION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0029908056     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.85.6.1108     Document Type: Article

References (23)

1. Barone FC, Hillegass LM, Price WJ, et al: Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histology verification. J Neurosci Res 29:336-345, 1994
2. Bevilacqua MP, Nelson RM, Mannori G, et al: Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med 45:361-378, 1994
3. Bowes MP, Rothlein R, Fagan SC, et al: Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy ot thrombolytic therapy. Neurology 45:815-819, 1995
4. Bradley PP, Priebat DA, Christensen RD, et al: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209, 1982
5. Carter LP, Guthkelch AN, Orozco J, et al: Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model. Stroke 23:883-888, 1992
6. Crowell JW, Sharpe GP, Lambright RL, et al: The mechanism of death after resuscitation following acute circulatory failure. Surgery 38:696-702, 1955
7. Crowell RM, Olsson Y, Klatzo I, et al: Temporary occlusion of the middle cerebral artery in the monkey: clinical and pathological observations. Stroke 1:439-448, 1970
8. Hardaway RM, Elovitz MJ, Brewster WR Jr, et al: Clotting time of heparinized blood. Influence of acidosis. Arch Surg 89: 701-705, 1964
9. Jones TH, Morawetz RB, Crowell RM, et al: Threshold of focal cerebral ischemia in awake monkeys. J Neurosurg 54: 773-782, 1981
10. Kaplan B, Brint S, Tanabe J, et al: Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke 22:1032-1039, 1991
11. Kay R, Wong KS, Woo J: Pilot study of low-molecular-weight heparin in the treatment of acute ischemic stroke. Stroke 25: 684-685, 1994
12. Kochanek PM, Hallenbeck JM: Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23:1367-1379, 1992
13. Matsuo Y, Kihara T, Ikeda M, et al: Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: effect of neutrophil depletion on extracellular ascorbyl radical formation. J Cereb Blood Flow Metab 15:941-947, 1995
14. Ogawa A, Sato H, Sakurai Y, et al: Limitation of temporary vascular occlusion during aneurysm surgery. Study by intraoperative monitoring of cortical blood flow. Surg Neurol 36: 453-457, 1991
15. Pulsinelli WA: The therapeutic window in ischemic brain injury. Curr Opin Neurol 8:3-5, 1995 (Editorial)
16. Smith DR, Ducker TB, Kempe LG: Temporary experimental intracranial vascular occlusion. Effect of massive doses of heparin on brain survival. J Neurosurg 30:537-544, 1969
17. Sundt TM Jr, Grant WC, Garcia JH: Restoration of middle cerebral artery flow in experimental infarction. J Neurosurg 31: 311-322, 1969
18. Sundt TM Jr, Waltz AG: Hemodilution and anticoagulation. Effects on the microvasculature and microcirculation of the cerebral cortex after arterial occlusion. Neurology 17:230-238, 1967
19. Yanaka K, Camarata PJ, Spellman SR, et al: Optimal timing of hemodilution for brain protection in a canine model of focal cerebral ischemia. Stroke 27:906-912, 1996
20. Yanaka K, Camarata PJ, Spellman SR, et al: Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats. J Neurosurg 85: 125-130, 1996
21. Yanaka K, Spellman SR, McCarthy JB, et al: Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia. I. Protective mechanism. J Neurosurg 85:1102-1107, 1996
22. Zea Longa E, Weinstein PR. Carlson S, et al: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91, 1989
23. Zhang RL, Chopp M, Jiang N, et al: Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26:1438-1443, 1995